Viewing Study NCT00816660


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2025-12-27 @ 11:51 PM
Study NCT ID: NCT00816660
Status: COMPLETED
Last Update Posted: 2021-05-03
First Post: 2009-01-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Sponsor: Baxalta now part of Shire
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module